Description
A potent inverse agonist of LRH-1 (IC50 = 320 nM) with maximum efficacy of 40% repression; inactive at the related SF1 transcriptional activator; alters the expression of haptoglobin, SAA1, and SAA4, induces the death of MDA-MB-231 breast cancer cells, and inhibits the StAR promoter (IC50 = 2.12 µM)
Formal name: 3-cyclohexyl-6-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]-2,4(1H,3H)-pyrimidinedione
Synonyms: CID-45100448
Molecular weight: 422.4
CAS: 1883548-87-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Inverse Agonists||Research Area|Cancer|Transcription Factors||Research Area|Endocrinology & Metabolism|Hormones & Receptors